GB1472624A - Enteric disease vaccine - Google Patents

Enteric disease vaccine

Info

Publication number
GB1472624A
GB1472624A GB3827974A GB3827974A GB1472624A GB 1472624 A GB1472624 A GB 1472624A GB 3827974 A GB3827974 A GB 3827974A GB 3827974 A GB3827974 A GB 3827974A GB 1472624 A GB1472624 A GB 1472624A
Authority
GB
United Kingdom
Prior art keywords
plasmid
vaccine
formalin
modified
coli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3827974A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canadian Patents and Development Ltd
Original Assignee
Canadian Patents and Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canadian Patents and Development Ltd filed Critical Canadian Patents and Development Ltd
Priority to GB3827974A priority Critical patent/GB1472624A/en
Priority to ZA00755043A priority patent/ZA755043B/xx
Priority to NL7510120A priority patent/NL7510120A/nl
Priority to DK386875A priority patent/DK386875A/da
Priority to AU84409/75A priority patent/AU8440975A/en
Priority to JP50105851A priority patent/JPS5151514A/ja
Priority to BE159657A priority patent/BE832967A/xx
Priority to FR7526861A priority patent/FR2282908A1/fr
Priority to DE19752538994 priority patent/DE2538994A1/de
Publication of GB1472624A publication Critical patent/GB1472624A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB3827974A 1974-09-02 1974-09-02 Enteric disease vaccine Expired GB1472624A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB3827974A GB1472624A (en) 1974-09-02 1974-09-02 Enteric disease vaccine
ZA00755043A ZA755043B (en) 1974-09-02 1975-08-05 Enteric disease vaccine
NL7510120A NL7510120A (nl) 1974-09-02 1975-08-27 Werkwijze voor de bereiding van een vaccin tegen ingewandsstoornissen.
DK386875A DK386875A (da) 1974-09-02 1975-08-28 Fremgangsmade til fremstilling af en vaccine mod tarmsygdomme
AU84409/75A AU8440975A (en) 1974-09-02 1975-08-29 E. coli vaccine
JP50105851A JPS5151514A (en) 1974-09-02 1975-09-01 Seisankinwakuchinno seizoho
BE159657A BE832967A (fr) 1974-09-02 1975-09-01 Vaccins contre les enterites
FR7526861A FR2282908A1 (fr) 1974-09-02 1975-09-02 Vaccin contre la colibacillose
DE19752538994 DE2538994A1 (de) 1974-09-02 1975-09-02 Bakterieller impfstoff und verfahren zu seiner herstellung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3827974A GB1472624A (en) 1974-09-02 1974-09-02 Enteric disease vaccine

Publications (1)

Publication Number Publication Date
GB1472624A true GB1472624A (en) 1977-05-04

Family

ID=10402419

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3827974A Expired GB1472624A (en) 1974-09-02 1974-09-02 Enteric disease vaccine

Country Status (9)

Country Link
JP (1) JPS5151514A (nl)
AU (1) AU8440975A (nl)
BE (1) BE832967A (nl)
DE (1) DE2538994A1 (nl)
DK (1) DK386875A (nl)
FR (1) FR2282908A1 (nl)
GB (1) GB1472624A (nl)
NL (1) NL7510120A (nl)
ZA (1) ZA755043B (nl)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0102831A1 (en) * 1982-09-02 1984-03-14 Unilever N.V. Production of antibodies
WO1985005037A1 (en) * 1984-05-02 1985-11-21 Syn-Tek Ab Adhesin antigens, antibodies and dna fragment encoding the antigen, methods and means for diagnosis and immunization etc.
US4971794A (en) * 1982-09-02 1990-11-20 Unilever Patent Holdings B.V. Production of antibodies using a mixture of strains of E. coli collectively expressing type I pili, CFA I pili, CFA II pili and K88 pili
US5066596A (en) * 1984-02-01 1991-11-19 Enterovax Limited Bacterial strains harboring cloned genes controlling vibrio cholerae o-antigen biosynthesis
US5137721A (en) * 1981-03-09 1992-08-11 Cetus Corporation Employing strains of E. coli expressing non-indigenous adhesins and toxoids of E. coli
WO1992014487A1 (en) * 1991-02-26 1992-09-03 Jan Holmgren Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2466251B1 (fr) * 1979-10-03 1983-03-18 Agronomique Inst Nat Rech Vaccin animal anticolibacillaire, obtention et application
IL59663A (en) * 1980-03-19 1983-02-23 Univ Ramot Vaccines obtained from bacterial mutant strains of enterobacteriaceae and pseudomonaceae
WO1982003088A1 (en) * 1981-03-09 1982-09-16 Corp Cetus Vaccines
CA1338705C (en) * 1981-10-22 1996-11-12 Roy Curtiss Iii Vaccines obtained from antigenic gene products of recombinant genes
DE69322092T2 (de) * 1992-09-04 1999-07-15 University Of Saskatchewan, Saskatoon Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137721A (en) * 1981-03-09 1992-08-11 Cetus Corporation Employing strains of E. coli expressing non-indigenous adhesins and toxoids of E. coli
EP0102831A1 (en) * 1982-09-02 1984-03-14 Unilever N.V. Production of antibodies
US4971794A (en) * 1982-09-02 1990-11-20 Unilever Patent Holdings B.V. Production of antibodies using a mixture of strains of E. coli collectively expressing type I pili, CFA I pili, CFA II pili and K88 pili
US5066596A (en) * 1984-02-01 1991-11-19 Enterovax Limited Bacterial strains harboring cloned genes controlling vibrio cholerae o-antigen biosynthesis
WO1985005037A1 (en) * 1984-05-02 1985-11-21 Syn-Tek Ab Adhesin antigens, antibodies and dna fragment encoding the antigen, methods and means for diagnosis and immunization etc.
US5804198A (en) * 1984-05-02 1998-09-08 Symbicom Aktiebolag Vaccines against disease caused by pathogenic pilus-forming bacteria
US6291649B1 (en) 1984-05-02 2001-09-18 Symbicom Aktiebolag Anti-bodies binding adhesin-derived antigens
WO1992014487A1 (en) * 1991-02-26 1992-09-03 Jan Holmgren Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans
US6558678B1 (en) 1991-02-26 2003-05-06 Jan Holmgren Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans

Also Published As

Publication number Publication date
NL7510120A (nl) 1976-03-04
AU8440975A (en) 1977-03-03
BE832967A (fr) 1975-12-31
DE2538994A1 (de) 1976-06-16
DK386875A (da) 1976-03-03
ZA755043B (en) 1976-06-30
FR2282908A1 (fr) 1976-03-26
FR2282908B1 (nl) 1978-11-10
JPS5151514A (en) 1976-05-07

Similar Documents

Publication Publication Date Title
Fouz et al. First description of non‐motile Yersinia ruckeri serovar I strains causing disease in rainbow trout, Oncorhynchus mykiss (Walbaum), cultured in Spain
Goldberg et al. Characterization of a Na+/H+ antiporter gene of Escherichia coli.
GB1472624A (en) Enteric disease vaccine
US4336336A (en) Fused gene and method of making and using same
Bölin et al. Identification and mapping of the temperature-inducible, plasmid-encoded proteins of Yersinia spp
ES8600649A1 (es) Un metodo de producir una forma geneticamente estable de vidrio cholerae
AU554080B2 (en) Production of viral antisens
Meynell et al. The nature and incidence of conjugation factors in Escherichia coli
Minkley Jr et al. Identification of a membrane protein associated with expression of the surface exclusion region of the F transfer operon
Johnson et al. Genetic transfer of the Vi antigen from Salmonella typhosa to Escherichia coli
Baron et al. Use of Vi phage lysates in genetic transfer
AU5329279A (en) Feline infectious peritonitis vaccine
BR112020017431A2 (pt) Expressão de proteína a de superfície pneumocócica (pspa)
Snellings et al. Genetic basis of Vi antigen expression in Salmonella paratyphi C
Henriksen et al. Transformation of twitching strains of Streptococcus sanguis
Sharpe et al. Common antigenic determinant in a rumen organism and in Salmonellae containing the antigen O4
Paditi et al. Characterization and Identification of Spiroplasmas by Polyacrylamide Gel Electrophoresis.
Lassen et al. Serotype-related HEp-2 cell interaction of Yersinia enterocolitica
KAGEYAMA et al. Genetic mapping of pyocin R3 factor in Pseudomonas aeruginosa
GB1358321A (en) Method od tissue cell culture
Thiele Virulence of R-factor-bearing Salmonella typhimurium
CN103805532A (zh) 一种坏死梭杆菌重组omp蛋白及制备方法
KITANO Male specific bacteriophage in Shigella flexneri I. Formation of male Shigella flexneri by F'mediated transfer with Escherichia coli
Hashimoto et al. Genetic structure of an R factor conferring ampicillin resistance
ES8104402A1 (es) Procedimiento para la preparacion de medicamentos inmunobio-terapicos a partir de cepas microbiologicas.

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee